HOT TOPICS IN CATHETER-DIRECTED TREATMENTS FOR PULMONARY EMBOLISM

Saturday, March 8, 2025

9:00 AM – 10:00 AM ET

Moderator(s)

Suhail Dohad, MD

Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
Cedars Sinai Medical Center
Beverly Hills, California, United States

Disclosure(s): Abbott Vascular, Boston Scientific, Penumbra, Phillips, ReCOR/Otsuka Pharmaceuticals, Johnson and Johnson: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

Riyaz Bashir, MD

Director Vascular and Endovascular Medicine
Temple University Hospital
Mount Laurel, New Jersey, United States

Disclosure(s): Thrombolex: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jay Giri, MD, MPH

Interventional Cardiologist
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Disclosure(s): Boston Scientifiic: Consultant (Ongoing); Inari Medical: Consultant (Ongoing)
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Suhail Dohad, MD: Abbott Vascular, Boston Scientific, Penumbra, Phillips, ReCOR/Otsuka Pharmaceuticals, Johnson and Johnson: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Riyaz Bashir, MD: Thrombolex: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Jay Giri, MD, MPH: Boston Scientifiic: Consultant (Ongoing); Inari Medical: Consultant (Ongoing)

Eric A. Secemsky, MD, MSc: Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)